Boehringer Ingelheim’s unbranded adalimumab-adbm biosimilar will be available at an 81% discount to adalimumab (Humira).
Killian Meara
Advertisement
Articles by Killian Meara
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Lilly Announces Partnership with Walmart Pharmacy Launching First Retail Pick-Up Option Offering Direct-To-Consumer Priced Zepbound
2
Emotional Support as Strategy
3
Why DTC Drug Models Must Evolve From Access to True Patient Support
4
